Plasma Myostatin is only a Weak Predictor for Weight Maintenance in Obese Adults

Abstract

Background: Predicting an individual’s success in a non-surgical weight loss approach is a demanding need since obesity is becoming an epidemic burden. A possible predictive marker is myostatin, a member of the transforming growth factor b superfamily, which has been shown to be an important regulator of muscle homeostasis.

Methods: In the present study, we analyzed myostatin as a marker to predict weight loss of patients that participated in a 2 phased weight reduction program, comprising a weight loss period of 12 weeks and a weight stabilization period of 40 weeks. Therefore, 62 obese individuals with a mean BMI of 40.6 kg/m² were included. Plasma myostatin was measured with ELISA at the beginning (T0), after weight loss (T1) and at the end of the program (T2).

Results: Although significant weight loss of −23.9±14.9 kg was achieved, myostatin did not change significantly during the program (T0>T1: p=0.46; T1>T2: p=0.70; T0>T2: p=0.57). Myostatin at baseline did neither negatively correlate with the achieved weight loss in the weight reduction phase (T0>T1: r=0.27, p=0.16) nor with weight loss during the whole program (T0>T2: r=0.20, p=0.29). Only a minor correlation with myostatin levels after weight loss with weight regain during maintenance period was detected. (T1>T2: r=−0.37, p=0.05).

Conclusion: Plasma myostatin might be suitable in predicting weight regain after marked weight loss, but no association with weight loss was observed in patients undergoing a non-surgical weight loss program. Therefore, myostatin does not seem to be a predictor for success in non-surgical weight loss approaches.

Key words

myostatin - obesity - weight reduction - weight stabilization

^* Authors contributed equally to this study.

• References

• 1 Bischoff SC, Damms-Machado A, Betz C et al. Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life – a prospective study. Int J Obes (Lond) 2012; 36: 614-624
• 2 Winkler JK, Woehning A, Schultz JH et al. TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients. Nutrition 2012; 28: 996-1001
• 3 Woehning A, Schultz JH, Roeder E et al. The A-allele of the common FTO gene variant rs9939609 complicates weight maintenance in severe obese patients. Int J Obes (Lond) 2013; 37: 135-139
• 4 Guo T, Jou W, Chanturiya T et al. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009; 4: e4937
• 5 Hittel DS, Axelson M, Sarna N et al. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc 2010; 42: 2023-2029
• 6 McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90
• 7 Motevalli MS, Dalbo VJ, Attarzadeh RS et al. The effect of rate of weight reduction on serum myostatin and follistatin concentrations in competitive wrestlers. Int J Sports Physiol Perfor 2015; 10: 139-146
• 8 Jensky NE, Sims JK, Rice JC et al. The influence of eccentric exercise on mRNA expression of skeletal muscle regulators. Eur J Appl Physiol 2007; 101: 473-480
• 9 Ehehalt S, Schweizer R, Blumenstock G et al. DISKUS-Study Group . Investigation of myostatin serum levels before and after a 6-month lifestyle intervention program in obese children. Exp Clin Endocrinol Diabetes 2011; 119: 238-242
• 10 Buehring B, Binkley N. Myostatin – the holy grail for muscle, bone, and fat?. Curr Osteoporos Rep 2013; 11: 407-414
• 11 Langley B, Thomas M, Bishop A et al. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002; 277: 49831-4940
• 12 Zhao B, Li EJ, Wall RJ et al. Coordinated patterns of gene expressions for adult muscle build-up in transgenic mice expressing myostatin propeptide. BMC Genomics 2009; 10: 305
• 13 Hittel DS, Berggren JR, Shearer J et al. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 2009; 58: 30-38
• 14 Hulmi JJ, Kovanen V, Selänne H et al. Acute and long-term effects of resistance exercise with or without protein ingestion on muscle hypertrophy and gene expression. Amino Acids 2009; 37: 297-308
• 15 Kim JS, Cross JM, Bamman MM. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol Endocrinol Metab 2005; 288: E1110-E1119
• 16 Louis E, Raue U, Yang Y et al. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol 2007; 103: 1744-1751
• 17 Matsakas A, Bozzo C, Cacciani N et al. Effect of swimming on myostatin expression in white and red gastrocnemius muscle and in cardiac muscle of rats. Exp Physiol 2006; 91: 983-994
• 18 Walker KS, Kambadur R, Sharma M et al. Resistance training alters plasma myostatin but not IGF-1 in healthy men. Med Sci Sports Exerc 2004; 36: 787-793
• 19 Willoughby DS. Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc 2004; 36: 574-582
• 20 Milan G, Dalla Nora E, Pilon C et al. Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab 2004; 89: 2724-2727
• 21 Park JJ, Berggren JR, Hulver MW et al. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol Genomics 2006; 27: 114-121
• 22 Wilkes JJ, Lloyd DJ, Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 2009; 58: 1133-1143
• 23 Allen DL, Cleary AS, Speaker KJ et al. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 2008; 294: E918-E927
• 24 Breitbart A, Scharf GM, Duncker D et al. Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients. PLoS One 2013; 8: e80454
• 25 Elliott B, Renshaw D, Getting S et al. The central role of myostatin in skeletal muscle and whole body homeostasis. Acta Physiol (Oxf) 2012; 205: 324-340
• 26 McNally EM. Powerful genes – myostatin regulation of human muscle mass. N Engl J Med 2004; 350: 2642-2644
• 27 Sharma M, Langley B, Bass J et al. Myostatin in muscle growth and repair. Exerc Sport Sci Rev 2001; 29: 155-158
• 28 Winkler JK, Schultz JH, Woehning A et al. Effectiveness of a low-calorie weight loss program in moderately and severely obese patients. Obes Facts 2013; 6: 469-480
• 29 Miller CT, Fraser SF, Levinger I et al. The effects of exercise training in addition to energy restriction on functional capacities and body composition in obese adults during weight loss: a systematic review. PLoS One 2013; 25 8: e81692
• 30 Allen DL, Hittel DS, McPherron AC. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc 2011; 43: 1828-1835
• 31 Ryan AS, Li G, Blumenthal JB et al. Aerobic exercise+weight loss decreases skeletal muscle myostatin expression and improves insulin sensitivity in older adults. Obesity 2013; 21: 1350-1356